Cervical Cancer:
Phase 1b Study of Polyphenon E for Cervical Cancer Prevention
Who is conducting the study? This National Cancer Institute-funded study will be conducted by Arizona Cancer Center researchers at the University of Arizona.
Principal Investigator: Francisco Garcia, MD, MPH
What is the purpose of the Study? The purpose of this randomized, placebo-controlled study is to evaluate the effect of Polyphenon E (a defined green tea extract) on persistent precancerous cells of the cervix.
How long is the study? To participate, patients are asked to devote a 6 month time period to the study.
Who is eligible for the study?
Participants must meet the following criteria for inclusion:
- Age 18 or older
- Persistent mild dysplasia (precancerous cells of the cervix) 6-12 months prior to enrollment
Participants will be excluded for the following criteria:
- Treatment for genital condyloma within 30 days prior to screening
- HIV positive
- Prior pelvic irradiation
- Prior malignancy other than non-melanoma skin cancer
- Pregnant, nursing, or inadequate contraceptive measures
- Tea drinkers who have consumed more than 6 cups of green tea prior to enrollment
What is required during the study?
- Blood test to determine normal liver and kidney function
- Cannot be pregnant, and must be willing to use an effective contraception for the duration of the study
- 6 clinic visits – willing to come to the clinic every month for 4 months
- Take 4 study capsules every morning for 16 weeks
- Keep a study diary for 18 weeks
- Avoid any tea or tea products for the duration of the study
What to expect at your visit:
- Urine
- Pregnancy testing
- Pap smear
- Colposcopy
- Possible cervical biopsy
- Digital photography of the cervix
- Cervical specimens for HPV testing
- Blood draw
For more information, please contact:
Bonita Weible
(520) 318-7178
back to featured clinical trials
To search for clinical trials at the Arizona Cancer Center, Click Here